XML 102 R61.htm IDEA: XBRL DOCUMENT v3.25.4
Segment and Enterprise Reporting (Tables)
 12 Months Ended
Jan. 03, 2026
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
Selected information for the healthcare segment is presented below for each of the years ended January 3, 2026, December 28, 2024 and December 30, 2023:
(in millions)Year Ended
January 3,
2026		Year Ended
December 28,
2024		Year Ended
December 30,
2023
Revenues:
Healthcare$1,524.1 $1,395.2 $1,275.5 
Other(1)
2.8 — — 
Total revenues$1,526.9 $1,395.2 $1,275.5 
Cost of goods:
Healthcare$573.8 $581.7 $498.3 
Other(1)
7.9 19.2 11.6 
Total costs of good sold$581.7 $600.9 $509.9 
Gross profit:
Segment gross profit$950.3 $813.6 $777.1 
Acquired asset amortization(1)(2)
(6.6)(1.8)(1.9)
Business transition and related costs(1)(3)
1.5 (14.8)(4.9)
Acquisitions, integrations, divestitures, and related costs(1)(4)
— (0.1)— 
Other(1)
— (2.6)(4.7)
Total gross profit$945.2 $794.3 $765.6 
__________________
(1)    Management excludes certain revenues and expenses from segment gross profit. Management considers these excluded amounts to be non-recurring or non-operational and as such, are excluded from segment gross profit as this enables management to better understand operational results.
(2)    Acquired asset amortization is a non-GAAP financial measure. These transactions represent amortization expense in connection with business or assets acquisitions associated with acquired intangible assets including, but not limited to customer relationships, intellectual property, trade names and non-competition agreements.
(3)    Business transition and related costs are a non-GAAP financial measure. These transactions represent gains, losses, and other related costs associated with business transition plans. These items may include but are not limited to severance, relocation, consulting, leasehold exit costs, asset impairment, and other related costs to rationalize our operational footprint and optimize business results.
(4)    Acquisitions, integrations, divestitures, and related costs are a non-GAAP financial measure. These transactions represent gains, losses, and other related costs associated with acquisitions, integrations, investments, divestitures, assets impairments, and in-process research and development.
For each of the years ended January 3, 2026, December 28, 2024 and December 30, 2023, total depreciation and amortization expense for the healthcare segment was $38.8 million, $48.5 million and $38.1 million, respectively.
The Company’s total assets by segment are as follows:
(in millions)January 3,
2026		December 28,
2024
Total assets by segment:
Healthcare$1,697.8 $1,589.7 
Asset held-for-sale
1.1 1,036.0 
Total assets by segment$1,698.9 $2,625.7 
The Company’s consolidated long-lived assets (tangible non-current assets) by geographic area are as follows:
(in millions, except percentages)
Year Ended
January 3,
2026		Year Ended
December 28,
2024
Total long-lived assets by geographic area:
United States$307.7 86.5 %$312.5 87.9 %
International48.2 13.5 43.2 12.1 
Total long-lived assets by geographic area$355.9 100.0 %$355.7 100.0 %
The following schedule presents an analysis of the Company’s revenues based upon the geographic area (ship to location):
(in millions, except percentages)
Year Ended
January 3,
2026		Year Ended
December 28,
2024		Year Ended
December 30,
2023
Total revenue by geographic area:
United States (U.S.)$956.6 62.7 %$889.3 63.7 %$796.9 62.5 %
Europe, Middle East and Africa391.4 25.6 349.7 25.1 312.3 24.5 
Asia and Australia119.6 7.8 105.2 7.5 117.6 9.2 
North and South America (excluding U.S.)59.3 3.9 51.0 3.7 48.7 3.8 
     Total revenue by geographic area$1,526.9 100.0 %$1,395.2 100.0 %$1,275.5 100.0 %